Drug-Coated Balloon in Patients With High Bleeding Risk

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
DCB-HBR trial is prospective, multi-center, open-label, randomized controlled, noninferiority trial. The aim of the study is to compare clinical outcomes of drug-coated balloon (DCB) with drug-eluting stent (DES) for treatment of de-novo coronary lesion under intravascular imaging-guided optimization in patients with high bleeding risk (HBR).
Epistemonikos ID: f531d4ddc8737b1a0a47e68846c7dbf595c2d84d
First added on: May 10, 2024